Role of Nonstatin Therapies for LDL-Cholesterol Lowering: Home Study

Target Audience

All pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:

 

Identify patients who would be candidates for nonstatin LDL-cholesterol lowering medications
Discuss the 2022 ACC Expert Consensus regarding the decision pathway on initiation of nonstatin LDL-cholesterol lowering medications
State evidence supporting use of nonstatin LDL-cholesterol lowering medications
Name pharmacotherapy pearls of specific nonstatin LDL-cholesterol lowering medications

Course summary

Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
04/12/2023
Course expires: 
04/09/2026
Cost:
$10.00
Rating: 
0

Rachel Arnold, PharmD, PGY1 Pharmacy Resident

Attended The University of Kansas School of Pharmacy. Plans to complete PGY2 at The Brooklyn Hospital Center next year in Ambulatory Care

ACPE UAN # 0042-0000-23-024-H01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$10.00
Please login or register to take this course.

Required Hardware/software

You will need a device that allows you to hear and see the presentation. Some phones may have limited functionality.